Cubist Pharmaceuticals, Inc. Appoints Robert J. Perez To Board Of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free 

GenePool newsletter today!

Cubist (NASDAQ: CBST) today announced the appointment of Robert J. Perez to its Board of Directors. Since 2012, Mr. Perez has served as Cubist’s President and Chief Operating Officer (COO). The Company also announced that in accordance with its Corporate Governance Guidelines regarding term limits, three long-serving Directors, Dr. Michael B. Wood, Dr. Martin Rosenberg, and J. Matthew Singleton, each submitted a revocable resignation letter thereby notifying the Company of their intent to retire from the Board effective at the Company’s 2014 Annual Meeting of Stockholders.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC